Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: Sacituzumab govitecan

OS benefit of sacituzumab govitecan in pre-treated HR-positive/HER2-negative metastatic breast cancer

Presented By
Prof. Hope Rugo, Helen Diller Family Comprehensive Cancer Centre, CA, USA
Trial
Phase 3, TROPiCS-02
Conference
ESMO 2022

16 November, 2022 17:43

Sacituzumab govitecan meets primary endpoint 

Presented By
Prof. Hope Rugo, University of California San Francisco, CA, USA
Trial
Phase 3, TROPiCS-02
Conference
ASCO 2022

5 August, 2022 12:11

Sacituzumab govitecan effective in platinum-refractory metastatic urothelial cancer

Presented By
Dr Petros Grivas, University of Washington, WA, USA
Trial
Phase 2, TROPHY-U-01
Conference
ASCO GU 2022

8 April, 2022 11:16

Second-line sacituzumab govitecan improves survival in metastatic TNBC

Conference
ESMO 2020

25 November, 2020 15:14

Second- and third-line treatment options in mUC

Conference
ESMO 2020

25 November, 2020 14:41

Understanding MIBC biology for novel treatment options

Presented By
Prof. Yohann Loriot, Université Paris-Saclay, France
Trial
BLC2001; THOR; EV-301; EV-302; TROPHY-U-01; RANGE
Conference
EAU 2020

20 August, 2020 12:36

Enfortumab vedotin highly active in previously treated advanced urothelial carcinoma

Presented By
Dr Daniel P. Petrylak, Yale School of Medicine, USA
Trial
EV-201, EV-301
Conference
ASCO 2019

15 July, 2019 13:42
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy